Inogen Inc (NAS:INGN)
$ 8.43 0 (0%) Market Cap: 200.79 Mil Enterprise Value: 100.27 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 79/100

Inogen Inc at Stifel Healthcare Conference (Virtual) Transcript

Nov 17, 2021 / 08:20PM GMT
Release Date Price: $33.06 (-1.20%)
Matt Blackman
Stifel Financial Corporation - Analyst

Hi. Good afternoon, everyone. My name is Matt Blackman, member of the Stifel medtech research team, and thank you for joining us for this session with the senior leadership of Inogen. With us today, we have Nabil Shabshab, President and CEO; and Ali Bauerlein, CFO and Executive Vice President of Finance.

For today's discussion, I thought we would break it up into three distinct pieces. First, how to think about the shape of the business post COVID, and all the investments you're making today, and some of the newer initiatives that you are making as well and all to support future revenue growth. Second, we will talk about what you saw on the third quarter, the puts and the takes, and how that informs the nearer-term outlook.

And then finally, third, how we should be thinking about the longer-term sustainable growth and profitability trajectory of Inogen post COVID. As a reminder to everyone in the audience, this is a fireside chat meant to be interactive. So if you have a question, please type it in the question box on your screen,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot